More S'poreans Going Abroad for IVF to Choose Baby's Gender
By Asia One,
Asia One
| 08. 22. 2011
More and more Singaporeans are heading overseas for medical procedures which allow them to choose their babies' gender.
According to The Straits Times, foreign destinations such as the United States, and increasingly Thailand, let parents choose the gender of their babies through a procedure known as preimplantation genetic diagnosis (PGD), which is banned in Singapore.
These places are also well-known for their skills in in-vitro fertilisation (IVF).
Having sons important for people of Chinese ancestry
The managing director of Marvel IVF Solutions, an IVF facility in Bangkok, said 90 per cent of Singaporeans, Chinese nationals and Hong Kongers ask for boys.
That is because males are seen as heirs and capable of taking care of their siblings, the director said.
Other facilities such as Safe Fertility and PGD Centre in Bangkok and Fertility Institutes in Los Angeles also saw the same requests by Singaporean patrons, according to The Straits Times.
Embryos screened for gender or genetic diseases or both
PGD is carried out with IVF treatment and the embryos are screened for gender or genetic diseases or both, during the...
Related Articles
By Helen Floersh, Fierce Biotech | 11.10.2023
The images are unsettling, to put it mildly: a baby monkey whose skin grows eerily green, with glowing fingertips reminiscent of E.T.
This is “#10,” the world’s first live-born monkey that’s largely made up of embryonic stem cells, or ESCs...
Coded Bias is on Netflix; the trailer is
also at The Algorithmic Justice League
A few weeks ago, Marc Andreessen, a billionaire venture capitalist who got his start helping to create the first successful web browser, published The Techno-Optimist Manifesto on his website and caused something of a sensation. His screed characterizes Artificial Intelligence as, inter alia, “our alchemy, our Philosopher’s Stone” and “a universal problem solver.”
Not everyone agrees. In fact, the reaction of “techno-pessimists” (or realists) has been...
By Jonathan D. Grinstein, Genetic Engineering and Biotechnology News | 10.27.2023
Fyodor Urnov, PhD, is a pioneer in the field of genome editing and one of the scientists most invested in expanding the availability and utility of CRISPR-based therapies to the broadest possible population. He envisions a world in which genome...
By Jason Mast , STAT | 10.25.2023
PHILADELPHIA — Cesar de la Fuente believes the next breakthrough antibiotic might come from animals that have been dead for thousands of years.
Since 2021, his lab here at the University of Pennsylvania has built algorithms to trawl genetic databases...
